In continuation to our intimation letter dated May 12, 2021 and in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper advertisements regarding completion of dispatch of Notice of Postal Ballot dated May 10, 2021, published in Business Standard (English - Edition) and in Lokmat (Marathi Edition). A copy of the said advertisement is also hosted on the Company's website at www.strides.com This is for your information and records.
In line with the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we enclose herewith Notice of Postal Ballot dated May 10, 2021, seeking approval of Members for 'Re-appointment of Mr. Bharat Shah (DIN: 00136969) as an Independent Director of the Company'.
We wish to inform you that Board of Directors of the Company at their meeting held today i.e., May 10, 2021, based on the recommendation of the Nomination and Remuneration Committee and subject to the approval of the Members of the Company, have approved the proposal for re-appointment of Mr. Bharat Dhirajlal Shah (DIN: 00136969), as an Independent Director of the Company, for a second term of three years from June 15, 2021 upto June 14, 2024. The Company proposes to seek Members' approval for the above proposal by way of Postal Ballot. Additional details pursuant to Regulation 30 and other relevant provisions of the SEBI Listing Regulations is enclosed. This is for your information and record.
Pursuant to Regulation 40 (9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the Compliance Certificate for the half year ended on March 31, 2021 duly certified by the Practicing Company Secretary. Request you to kindly take the same on record.
Strides Pharma Science Ltd - 532531 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 121211 Name of the Signatory :- Manjula RamamurthyDesignation :- Company Secretary and Compliance Officer
Ref: Strides' intimation to stock exchanges dated October 1, 2020 regarding reclassification request received from SeQuent Scientific Limited (SeQuent) for reclassification from 'Promoter Group' to 'Public' Category; Strides' intimation to stock exchanges dated October 29, 2020 regarding Board approval for such reclassification; and Strides' intimation to stock exchanges dated March 17, 2021 regarding Members' approval for such reclassification. Further to the above, we wish to inform you that the Company has submitted an application with your office today i.e., on April 12, 2021, seeking your approval for the reclassification of SeQuent Scientific Limited from 'Promoter Group' to 'Public' category under Regulation 31A of SEBI Listing Regulations. Request you to kindly take the same on record and oblige.